Neogenomics

NEO

----

Will CEO Succession Plan Change NeoGenomics Stock Narrative
Simplywall·Oct 8, 2026 at 07:20 AM
NEO+2.06%
Analyst Maintains Hold Rating but Raises Price Target to $20 Amid Solid Fundamentals and Limited Near-Term Upside
Tip Ranks·Oct 7, 2026 at 08:55 AM
NEO+2.06%
Stryker, Neogenomics Announce CEO Transitions; Both Stocks Dive
Unusual Whales·Oct 6, 2026 at 09:14 PM
NEO+2.06%SYK+0.13%
General Motors To Rally Around 40%? Here Are 10 Top Analyst Forecasts For Tuesday
benzinga_article·Oct 6, 2026 at 12:54 PM
- Major Wall Street financial institutions have recently updated their price targets and ratings for several prominent publicly traded companies. - Key adjustments include BMO Capital raising PTC Inc price target to $205 and Goldman Sachs increasing General Motors Co price target to $112. - These rating changes reflect evolving market assessments from top analysts regarding companies across various sectors.
ACN+0.34%GM+0.58%
StoneX maintains Buy rating on NeoGenomics, $20 price target
TradingView·Oct 6, 2026 at 12:40 PM
NEO+2.06%
Needham maintains Buy rating on NeoGenomics, $22 price target
TradingView·Oct 6, 2026 at 11:12 AM
NEO+2.06%
NeoGenomics names Warren Stone CEO effective Jan. 4, 2027
PUBT·Oct 5, 2026 at 08:07 PM
NEO+2.06%
Strategic Pivots and Healthcare Milestones Dominate the Fringes
Global Report·Sep 22, 2026 at 10:14 AM
SMG-1.13%NINE-1.02%
Weekly Recap | Neogenomics +14.95%, closing in on record highs
Weekly Review·Sep 19, 2026 at 06:25 AM
NEO+2.06%
NeoGenomics to join Morgan Stanley Global Healthcare Conference fireside chat
PUBT·Sep 1, 2026 at 11:05 AM
NEO+2.06%
Weekly Recap | Neogenomics +6.3%, first-profit claim follows volume spike
Weekly Review·Aug 29, 2026 at 06:06 AM
NEO+2.06%